First drug to Alzheimer's progression gets approved in the US

The drug, manufactured by the pharmaceutical company Eisai in Tokyo and Biogen in Cambridge, Massachusetts, is given intravenously every other week.

from Articles | Mail Online https://ift.tt/3SCPrbq

Comments